BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18661166)

  • 1. Liposomal cytarabine given concomitantly with radiotherapy in a patient with leptomeningeal metastasis from breast cancer.
    Glas M; Stuplich M; Tschampa H; Urbach H; Rasch K; Herrlinger U
    J Neurol; 2008 Nov; 255(11):1838-9. PubMed ID: 18661166
    [No Abstract]   [Full Text] [Related]  

  • 2. [Meningeal carcinomatosis in cancer patients].
    Danova M; Invernizzi R
    Tumori; 2005; 91(5):10-21. PubMed ID: 16459648
    [No Abstract]   [Full Text] [Related]  

  • 3. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Niwińska A; Rudnicka H; Murawska M
    Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cerebrospinal fluid examination after liposomal cytarabine intrathecal injection].
    Guillaume C; Vegas H; Pastuszka A; Le Brun C; Lanotte P
    Ann Biol Clin (Paris); 2018 Oct; 76(5):568-570. PubMed ID: 30154068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Liposomal cytarabine for the treatment of leptomeningeal dissemination of central nervous system tumours in children and adolescents].
    Moreno L; García Ariza MA; Cruz O; Calvo C; Fuster JL; Salinas JA; Moscardo C; Portugal R; Merino JM; Madero L
    An Pediatr (Barc); 2016 Nov; 85(5):274.e1-274.e8. PubMed ID: 27086069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
    Mrugala MM; Kim B; Sharma A; Johnson N; Graham C; Kurland BF; Gralow J
    Clin Breast Cancer; 2019 Oct; 19(5):311-316. PubMed ID: 31175053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoplastic meningitis from breast carcinoma with complete response to liposomal cytarabine: case report.
    Gaviani P; Silvani A; Corsini E; Erbetta A; Salmaggi A
    Neurol Sci; 2009 Jun; 30(3):251-4. PubMed ID: 19259616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of leptomeningeal malignancy.
    Pentheroudakis G; Pavlidis N
    Expert Opin Pharmacother; 2005 Jun; 6(7):1115-25. PubMed ID: 15957966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis.
    Benesch M; Sovinz P; Krammer B; Lackner H; Mann G; Schwinger W; Gadner H; Urban C
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):222-6. PubMed ID: 17414563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal cytarabine (DepoCyte) for the treatment of neoplastic meningitis.
    Rueda Domínguez A; Olmos Hidalgo D; Viciana Garrido R; Torres Sánchez E
    Clin Transl Oncol; 2005 Jul; 7(6):232-8. PubMed ID: 16131445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience using intrathecal liposomal cytarabine to manage neoplastic meningitis in three patients with acute promyelocytic leukemia.
    Duarte RF; Arnan M; Sánchez-Ortega I; de Llano MP; Abellán PF
    Leuk Res; 2011 Jul; 35(7):e128-30. PubMed ID: 21501870
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report.
    Stemmler HJ; Mengele K; Schmitt M; Harbeck N; Laessig D; Herrmann KA; Schaffer P; Heinemann V
    Anticancer Drugs; 2008 Sep; 19(8):832-6. PubMed ID: 18690096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series.
    Chamberlain MC
    J Neurooncol; 2012 Aug; 109(1):143-8. PubMed ID: 22539243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rationale for the use of liposomal cytarabine in meningeal carcinomatosis].
    Boiardi A
    Tumori; 2007; 93(3):suppl 1-3. PubMed ID: 17679478
    [No Abstract]   [Full Text] [Related]  

  • 15. Leptomeningeal metastasis in melanoma: a prospective clinical study of nine patients.
    Pape E; Desmedt E; Zairi F; Baranzelli MC; Dziwniel V; Dubois F; Bonneterre J; Mortier L; Le Rhun E
    In Vivo; 2012; 26(6):1079-86. PubMed ID: 23160697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current diagnosis and treatment of leptomeningeal metastasis.
    DeAngelis LM
    J Neurooncol; 1998; 38(2-3):245-52. PubMed ID: 9696379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal depot cytarabine therapy: a welcome addition to a limited armamentarium.
    Bleyer WA
    Clin Cancer Res; 1999 Nov; 5(11):3349-51. PubMed ID: 10589743
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience with the intrathecal use of liposomal cytarabine at the Besta Institute].
    Silvani A
    Tumori; 2007; 93(3):suppl 6-8. PubMed ID: 17679480
    [No Abstract]   [Full Text] [Related]  

  • 19. Leptomeningeal melanomatosis: stabilization of disease due to radiation, temozolomide and intrathecal liposomal cytarabine.
    Schaefer N; Rasch K; Moehlenbruch M; Urbach H; Stuplich M; Blasius E; Scheffler B; Herrlinger U; Glas M
    Acta Oncol; 2011 Nov; 50(8):1260-2. PubMed ID: 21736503
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intrathecal chemotherapy treatment of neoplastic meningitis from solid tumors using liposomal cytarabine: experience at the Istituto Regina Elena di Roma].
    Pace A
    Tumori; 2007; 93(3):suppl 9-12. PubMed ID: 17679481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.